JP2021501760A5 - - Google Patents

Download PDF

Info

Publication number
JP2021501760A5
JP2021501760A5 JP2020524345A JP2020524345A JP2021501760A5 JP 2021501760 A5 JP2021501760 A5 JP 2021501760A5 JP 2020524345 A JP2020524345 A JP 2020524345A JP 2020524345 A JP2020524345 A JP 2020524345A JP 2021501760 A5 JP2021501760 A5 JP 2021501760A5
Authority
JP
Japan
Prior art keywords
alkyl
branched
linear
substituted
substituents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020524345A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021501760A (ja
JPWO2019086720A5 (enExample
JP7239246B2 (ja
Filing date
Publication date
Priority claimed from EP17382741.1A external-priority patent/EP3480201A1/en
Application filed filed Critical
Publication of JP2021501760A publication Critical patent/JP2021501760A/ja
Publication of JP2021501760A5 publication Critical patent/JP2021501760A5/ja
Publication of JPWO2019086720A5 publication Critical patent/JPWO2019086720A5/ja
Application granted granted Critical
Publication of JP7239246B2 publication Critical patent/JP7239246B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020524345A 2017-11-06 2018-11-06 アンドロゲン受容体調節因子及びグルココルチコイド受容体調節因子としての新規アナログ Active JP7239246B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17382741.1A EP3480201A1 (en) 2017-11-06 2017-11-06 New analogs as androgen receptor and glucocorticoid receptor modulators
EP17382741.1 2017-11-06
PCT/EP2018/080367 WO2019086720A1 (en) 2017-11-06 2018-11-06 New analogs as androgen receptor and glucocorticoid receptor modulators

Publications (4)

Publication Number Publication Date
JP2021501760A JP2021501760A (ja) 2021-01-21
JP2021501760A5 true JP2021501760A5 (enExample) 2021-12-16
JPWO2019086720A5 JPWO2019086720A5 (enExample) 2023-01-19
JP7239246B2 JP7239246B2 (ja) 2023-03-14

Family

ID=60327253

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020524345A Active JP7239246B2 (ja) 2017-11-06 2018-11-06 アンドロゲン受容体調節因子及びグルココルチコイド受容体調節因子としての新規アナログ

Country Status (21)

Country Link
US (1) US11453660B2 (enExample)
EP (2) EP3480201A1 (enExample)
JP (1) JP7239246B2 (enExample)
KR (1) KR102762303B1 (enExample)
CN (1) CN111491935B (enExample)
AU (1) AU2018361566B2 (enExample)
CA (1) CA3079804A1 (enExample)
DK (1) DK3707143T3 (enExample)
EA (1) EA202091148A1 (enExample)
ES (1) ES2941263T3 (enExample)
FI (1) FI3707143T3 (enExample)
HR (1) HRP20230270T1 (enExample)
HU (1) HUE061436T2 (enExample)
LT (1) LT3707143T (enExample)
MX (1) MX2020004688A (enExample)
PL (1) PL3707143T3 (enExample)
PT (1) PT3707143T (enExample)
RS (1) RS64101B9 (enExample)
SI (1) SI3707143T1 (enExample)
WO (1) WO2019086720A1 (enExample)
ZA (1) ZA202002920B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102737686B1 (ko) * 2021-09-10 2024-12-03 계명대학교 산학협력단 Jnj38877605를 유효성분으로 함유하는 비만 예방 또는 치료용 조성물
CN113979883A (zh) * 2021-12-08 2022-01-28 新华制药(寿光)有限公司 一种乙酰乙酰苯胺高效精制工艺及其设备
TWI864587B (zh) 2022-02-14 2024-12-01 美商基利科學股份有限公司 抗病毒吡唑并吡啶酮化合物
CN116496296A (zh) * 2022-09-02 2023-07-28 河南师范大学 具有抗肿瘤功用的度鲁特韦衍生物及其制备方法
WO2024229221A1 (en) * 2023-05-03 2024-11-07 Capulus Therapeutics, Llc Androgen receptor modulators and methods for their use
CN117298108A (zh) * 2023-09-07 2023-12-29 浙江师范大学 雄激素受体和糖皮激素受体双靶抑制剂及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4659717A (en) * 1985-08-21 1987-04-21 Eli Lilly And Company Dihydropyridines useful in the treatment of angina and stroke
US4902694A (en) * 1988-08-11 1990-02-20 Eli Lilly And Company Dihydropyridine calcium channel modulators
DE4321030A1 (de) * 1993-06-24 1995-01-05 Bayer Ag 4-bicyclisch substituierte Dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimittel
WO2005016885A2 (en) 2003-08-14 2005-02-24 Artesian Therapeutics, Inc. COMPOUNDS WITH COMBINED CALCIUM CHANNEL BLOCKER AND β-ADRENERGIC ANTAGONIST OR PARTIAL AGONIST ACTIVITIES FOR TREATMENT OF HEART DISEASE
US20060116369A1 (en) 2004-10-25 2006-06-01 Shyamlal Ramchandani Certain compounds, compositions, and methods
KR20070087602A (ko) * 2004-12-13 2007-08-28 아이알엠 엘엘씨 화합물 및 스테로이드성 수용체 및 칼슘 채널 활성의조절제로서의 조성물
WO2008070875A2 (en) * 2006-12-08 2008-06-12 Roskamp Research Llc Polyhydroquinoline compounds and dihydropyridine compounds for inhibiting beta-amyloid production
CL2007003609A1 (es) * 2006-12-14 2008-07-25 Bayer Schering Pharma Ag Compuestos derivados de dihidropiridinas sustituidas; proceso de preparacion; compuestos intermediarios; composicion farmaceutica; proceso para producir la composicion farmaceutica; y uso en el tratamiento de una enfermedad mejorada con la inhibicion
EP2178563A2 (en) 2007-07-06 2010-04-28 OSI Pharmaceuticals, Inc. Combination anti-cancer therapy comprising an inhibitor of both mtorc1 and mtorc2
TWI365185B (en) 2008-07-24 2012-06-01 Lilly Co Eli Amidophenoxyindazoles useful as inhibitors of c-met
EP2817019A4 (en) 2012-02-24 2016-04-06 Univ Chicago METHOD AND COMPOSITIONS RELATED TO GLUCOCORTICOIDREZEPTORANTAGONISM AND PROSTATE CANCER
US20180303807A1 (en) 2015-10-01 2018-10-25 John Katzenellenbogen Androgen receptor ligands

Similar Documents

Publication Publication Date Title
JP2021501760A5 (enExample)
JP2016531121A5 (enExample)
JP2017137291A5 (enExample)
JP2016506958A5 (enExample)
JP2018519343A5 (enExample)
JP2019104748A5 (enExample)
JP2016530310A5 (enExample)
JP2014015465A5 (enExample)
JP2017537940A5 (enExample)
RU2017126261A (ru) Аэолиновые соединения, замещенные конденсированной кольцевой системой
RU2019100164A (ru) Гетероциклическое соединение, используемое как ингибитор fgfr
JP2016518437A5 (enExample)
JP2018500343A5 (enExample)
RU2017111200A (ru) Циклогексилэтилзамещенные диаза- и триаза-трициклические соединения в качестве антагонистов индоламин-2,3-диоксигеназы для лечения рака
JP2017508789A5 (enExample)
JP2020512387A5 (enExample)
JP2018529650A5 (enExample)
JP2016519165A5 (enExample)
JP2016529235A5 (enExample)
JP2016537382A5 (enExample)
JP2017521436A5 (enExample)
RU2016142309A (ru) Пестицидно активные гетероциклические производные с серосодержащими заместителями
JP2016529319A5 (enExample)
JP2017508733A5 (enExample)
RU2017126260A (ru) Циклические соединения, замещенные конденсированной кольцевой системой